UI Hospitals and Clinics

Studies | Researchers

Clinical Research

Showing newest first. Show oldest first. Or order by title

  1. A Phase I Trial of High-Dose Ascorbate in Glioblastoma Multiforme
    John Buatti
  2. A randomized phase II study of Azacitidine in combination with Lenalidomide (NSC-703812) vs Azacitidine alone vs Azacitidine in combination with Vorinostat (NSC-701852) for Higher-Risk Myelodysplastic…
    Thomas Carter
  3. A Phase 2 Study of MLN8237 in Advanced / Metastatic Sarcoma
    Mohammed Milhem
  4. A Comprehensive Approach to Improve Medication Adherence in Pediatric ALL
    Ayman El-Sheikh
  5. A Phase II Evaluation of Dalantercept (NSC #757172, IND #116598), A Novel Soluble Recombinant Activin Receptor-Like Kinase 1 (ALK-1) Inhibitor Receptor-Fusion Protein, in the Treatment of Persistent o…
    David Bender
  6. A multi-center, open-label, single-arm, Phase 3b study of macitentan in patients with Pulmonary Arterial Hypertension to psychometrically validate the...
    Linda Cadaret
  7. A Randomized Phase III Trial Evaluating Pathologic Complete Response Rates in Patients with Hormone Receptor-Positive, HER2-Positive, Large Operable and Locally Advanced Breast Cancer Treated w
    Alexandra Thomas
  8. Prospective Randomized Phase II Trial of Pazopanib (NSC #737754, IND 75648) Versus Placebo in Patients With Progressive Carcinoid Tumors
    Nancy Sharma
  9. PARACHUTE IV: Percutaneous Ventricular Restoration in Chronic Heart Failure due to Ischmic Heart Disease. A Pivotal Trial to Establish Efficacy and...
    Vladamir Cotarlan
  10. Inflammation Inhibition for Microvascular and Autonomic Dysfunction in Obese Prediabetic Humans (INCITE)
    Gary L. Pierce
  11. Investigational Vaccine for Melanoma
    Mohammed Milhem
  12. A Phase 1b/II Trial of ALT-801 in Combination with Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer
    Daniel Vaena
  13. Combination of Chemotherapy Drugs for Women with HER2-Negative Breast Cancer
    Mark Karwal
  14. Effectiveness of the Drug BIBF 1120 in Treating Endometrial Cancer
    David Bender
  15. A Pilot Study of Longitudinal Communication Networks in Families at Risk of Colorectal Cancer
    Anne Ersig
  16. Study Researching Head and Neck Cancer
    Mohammed Milhem
  17. Randomized Trial for Newly Diagnosed High Risk B-Precursor Acute Lymphoblastic Leukemia
    Ayman El-Sheikh
  18. Factors Contributing to Low Screening Rates among Persons at Increased Risk for Colorectal Cancer
    Anne Ersig
  19. Study for Safety of the Drug Ruxolitnib
    Thomas Carter
  20. Effects of Vitamin D Replacement on Tumor Response and Survival Parameters
    Brian Link

We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.